Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Merus Nv (MRUS)  
$47.09 1.64 (3.37%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 57,730,000
Market Cap: 2.72(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.81 - $51.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Merus is a clinical-stage oncology company developing antibody therapeutics. Using its Biclonics® platform, Co. has produced and is developing the following candidates: MCLA-128 (zenocutuzumab) for the treatment of solid tumors that harbor Neuregulin 1 gene fusions; MCLA-117 for the treatment of acute myeloid leukemia; MCLA-158 for the treatment of solid tumors; and MCLA-145, developed in collaboration with Incyte Corporation, for the potential treatment of solid tumors and a hematological malignancy, B-cell lymphoma. Co. is also developing a late-stage pre-clinical candidate, MCLA-129 in collaboration with Betta Pharmaceuticals Co. Ltd., for the potential treatment of solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 25,576
Total Buy Value $0 $0 $0 $460,861
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 23,326 23,901 25,384
Total Sell Value $0 $582,962 $595,313 $621,008
Total People Sold 0 2 2 2
Total Sell Transactions 0 4 5 9
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 108
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   De Kruif John SVP & Chief Technology Officer   •       –      –    2021-08-12 4 OE $0.00 $0 D/D 5,572 18,069     -
   Lundberg Sven Ante President, CEO & PFO   •       •      –    2021-08-02 4 OE $12.54 $200,474 D/D 15,000 15,000     -
   Bakker Lex SVP, Chief Development Officer   •       –      –    2021-07-02 4 OE $1.93 $13,510 D/D 7,000 15,668     -
   Lampert Mark N 10% Owner   –       –       •   2021-07-02 4 S $20.75 $45,359,957 D/D (2,186,022) 311,210 -30%     
   Bakker Lex SVP, Chief Development Officer   •       –      –    2021-07-01 4 AS $21.00 $81,242 D/D (3,860) 8,668 32%     
   Lampert Mark N 10% Owner   –       –       •   2021-03-30 4 B $19.75 $5,925,000 D/D 300,000 462,015 2.45 -3%     
   Lundberg Sven Ante President, CEO & PFO   •       •      –    2021-03-25 4 GD $0.00 $0 D/D 74,000 0     -
   Lampert Mark N 10% Owner   –       –       •   2021-03-22 4 B $22.75 $1,808,625 D/D 79,500 435,121 2.45 -26%     
   Lampert Mark N 10% Owner   –       –       •   2021-03-16 4 B $23.00 $5,749,900 D/D 250,000 427,377 2.45 -28%     
   Lundberg Sven Ante President, CEO & PFO   •       •      –    2021-03-01 4 OE $12.54 $989,867 D/D 74,000 74,000     -
   Incyte Corp 10% Owner   –       –       •   2021-01-25 4 A $24.75 $8,662,500 D/D 350,000 3,550,000     -
   Lampert Mark N 10% Owner   –       –       •   2021-01-21 4 B $24.75 $20,905,830 D/D 844,680 426,206 2.45 -26%     
   Liu Hui EVP, CBO & Head of Merus US   •       –      –    2021-01-04 4 OE $0.00 $0 D/D 578 57,931     -
   De Kruif John SVP & Chief Technology Officer   •       –      –    2021-01-04 4 OE $0.00 $0 D/D 58 12,497     -
   Bakker Lex SVP, Chief Development Officer   •       –      –    2021-01-04 4 OE $0.00 $0 D/D 91 5,162     -
   Lampert Mark N 10% Owner   –       –       •   2020-12-18 4 B $16.05 $2,568,000 D/D 160,000 2,245,067 2.45 31%     
   Liu Hui EVP, CBO & Head of Merus US   •       –      –    2020-12-01 4 OE $0.00 $0 D/D 582 57,353     -
   Bakker Lex SVP, Chief Development Officer   •       –      –    2020-12-01 4 OE $0.00 $0 D/D 108 5,071     -
   De Kruif John SVP & Chief Technology Officer   •       –      –    2020-12-01 4 OE $0.00 $0 D/D 79 12,439     -
   Liu Hui EVP, CBO & Head of Merus US   •       –      –    2020-11-02 4 OE $0.00 $0 D/D 582 56,771     -
   Bakker Lex SVP, Chief Development Officer   •       –      –    2020-11-02 4 OE $0.00 $0 D/D 108 4,963     -
   De Kruif John SVP & Chief Technology Officer   •       –      –    2020-11-02 4 OE $0.00 $0 D/D 79 12,360     -
   Liu Hui EVP, CBO & Head of Merus US   •       –      –    2020-10-01 4 OE $0.00 $0 D/D 582 56,189     -
   Bakker Lex SVP, Chief Development Officer   •       –      –    2020-10-01 4 OE $0.00 $0 D/D 108 4,855     -
   De Kruif John SVP & Chief Technology Officer   •       –      –    2020-10-01 4 OE $0.00 $0 D/D 79 12,281     -
  108 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us